Summa

Summa is a declared insider of Accentis, with filings sourced from FSMA. Between 21 June 2024 and 27 February 2026, the trades on record add up to 8 filings.

No open-market sale appears; the market trades are 8 purchases worth €127k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 2 purchases and no sales.

In size, the median ticket on the buying side is €2,490. The 8 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The latest filing, published on 9 March 2026, reports an open-market purchase of €109 in Accentis. Filings reach the FSMA feed a median of 3 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by FSMA and describes the past, not future prices; it is not investment advice.